share_log
Reuters ·  Apr 29 10:11
Annovis Bio Inc - Efficacy in Cgic Endpoint Was Not Reached Due to Limited Number of Patients and Short Trial Duration
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment